Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide

Nancy L. Kanagy, John R. Charpie, Jamie Dananberg, R. Clinton Webb

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Nitric oxide (NO) has been postulated as a regulator of vascular reactivity, and the current study tested the hypothesis that NO-induced decreased sensitivity to vasoconstrictors persists following removal of NO. Endothelium-denuded segments of rat aorta were incubated 2-4 h at 37°C with the NO donor S-nitroso-N-acetylpenicillamine (SNAP). Incubation produced rightward shifts in concentration response curves for phenylephrine [i.e., half-maximum effective concentration (EC50; in μM): control = 0.016, NO 0.14], aluminum fluoride (i.e., EC50 in mM: control 1.66, NO = 2.29), and KCI (i.e., EC50 in mM: control = 5.9, NO = 23.9). Similar shifts were seen for two other NO donors. The SNAP-induced shift was not attenuated by a guanylyl cyclase inhibitor, LY-83583 (10 μM) and was not mimicked by 8- bromoguanosine 3',5'-cyclic monophosphate (100 μM). It was attenuated by 1,4-naphthoquinone (50 μM), an inhibitor of endogenous mono-ADP ribosyltransferases. NO incubation increased cGMP content (4.6 ± 0.8 vs. 1.5 ± 0.15 pmol/mg protein), an increase unaffected by 1,4-naphthoquinone (3.3 ± 1.0 pmol/mg protein) but prevented by LY-83583 (1.6 ± 0.36 pmol/mg protein). ADP ribosylation of three proteins was observed in membranes from HEK 293 cells: 88, 66, and 38 kDa. ADP ribosylation of the 38-kDa protein was stimulated in a concentration-dependent manner by NO but was not decreased by 1,4-naphthoquinone. In conclusion, NO produces a long-lasting inhibition of vascular contractility by both a cGMP-dependent and -independent mechanism. Based on the observations of 1,4-naphthoquinone, we conclude that the cGMP- independent mechanism is not stimulation of endogenous ADP ribosylation but some other covalent modification in the pathway that mediates contraction.

Original languageEnglish (US)
Pages (from-to)253-260
Number of pages8
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume271
Issue number1 Pt 2
StatePublished - Jul 1 1996

Fingerprint

Vasoconstrictor Agents
Nitric Oxide
6-anilino-5,8-quinolinedione
Adenosine Diphosphate
S-Nitroso-N-Acetylpenicillamine
Nitric Oxide Donors
Proteins
Blood Vessels
ADP Ribose Transferases
HEK293 Cells
Guanylate Cyclase
Phenylephrine
Endothelium
Aorta
Membranes
1,4-naphthoquinone

Keywords

  • adenosine 5'-monophosphate ribosylation
  • guanosine 3',5'-cyclic monophosphate
  • guanylyl cyclase
  • vascular smooth muscle

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide. / Kanagy, Nancy L.; Charpie, John R.; Dananberg, Jamie; Webb, R. Clinton.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 271, No. 1 Pt 2, 01.07.1996, p. 253-260.

Research output: Contribution to journalArticle

@article{51f03a77b026486b872ee9fe60c00582,
title = "Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide",
abstract = "Nitric oxide (NO) has been postulated as a regulator of vascular reactivity, and the current study tested the hypothesis that NO-induced decreased sensitivity to vasoconstrictors persists following removal of NO. Endothelium-denuded segments of rat aorta were incubated 2-4 h at 37°C with the NO donor S-nitroso-N-acetylpenicillamine (SNAP). Incubation produced rightward shifts in concentration response curves for phenylephrine [i.e., half-maximum effective concentration (EC50; in μM): control = 0.016, NO 0.14], aluminum fluoride (i.e., EC50 in mM: control 1.66, NO = 2.29), and KCI (i.e., EC50 in mM: control = 5.9, NO = 23.9). Similar shifts were seen for two other NO donors. The SNAP-induced shift was not attenuated by a guanylyl cyclase inhibitor, LY-83583 (10 μM) and was not mimicked by 8- bromoguanosine 3',5'-cyclic monophosphate (100 μM). It was attenuated by 1,4-naphthoquinone (50 μM), an inhibitor of endogenous mono-ADP ribosyltransferases. NO incubation increased cGMP content (4.6 ± 0.8 vs. 1.5 ± 0.15 pmol/mg protein), an increase unaffected by 1,4-naphthoquinone (3.3 ± 1.0 pmol/mg protein) but prevented by LY-83583 (1.6 ± 0.36 pmol/mg protein). ADP ribosylation of three proteins was observed in membranes from HEK 293 cells: 88, 66, and 38 kDa. ADP ribosylation of the 38-kDa protein was stimulated in a concentration-dependent manner by NO but was not decreased by 1,4-naphthoquinone. In conclusion, NO produces a long-lasting inhibition of vascular contractility by both a cGMP-dependent and -independent mechanism. Based on the observations of 1,4-naphthoquinone, we conclude that the cGMP- independent mechanism is not stimulation of endogenous ADP ribosylation but some other covalent modification in the pathway that mediates contraction.",
keywords = "adenosine 5'-monophosphate ribosylation, guanosine 3',5'-cyclic monophosphate, guanylyl cyclase, vascular smooth muscle",
author = "Kanagy, {Nancy L.} and Charpie, {John R.} and Jamie Dananberg and Webb, {R. Clinton}",
year = "1996",
month = "7",
day = "1",
language = "English (US)",
volume = "271",
pages = "253--260",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 Pt 2",

}

TY - JOUR

T1 - Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide

AU - Kanagy, Nancy L.

AU - Charpie, John R.

AU - Dananberg, Jamie

AU - Webb, R. Clinton

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Nitric oxide (NO) has been postulated as a regulator of vascular reactivity, and the current study tested the hypothesis that NO-induced decreased sensitivity to vasoconstrictors persists following removal of NO. Endothelium-denuded segments of rat aorta were incubated 2-4 h at 37°C with the NO donor S-nitroso-N-acetylpenicillamine (SNAP). Incubation produced rightward shifts in concentration response curves for phenylephrine [i.e., half-maximum effective concentration (EC50; in μM): control = 0.016, NO 0.14], aluminum fluoride (i.e., EC50 in mM: control 1.66, NO = 2.29), and KCI (i.e., EC50 in mM: control = 5.9, NO = 23.9). Similar shifts were seen for two other NO donors. The SNAP-induced shift was not attenuated by a guanylyl cyclase inhibitor, LY-83583 (10 μM) and was not mimicked by 8- bromoguanosine 3',5'-cyclic monophosphate (100 μM). It was attenuated by 1,4-naphthoquinone (50 μM), an inhibitor of endogenous mono-ADP ribosyltransferases. NO incubation increased cGMP content (4.6 ± 0.8 vs. 1.5 ± 0.15 pmol/mg protein), an increase unaffected by 1,4-naphthoquinone (3.3 ± 1.0 pmol/mg protein) but prevented by LY-83583 (1.6 ± 0.36 pmol/mg protein). ADP ribosylation of three proteins was observed in membranes from HEK 293 cells: 88, 66, and 38 kDa. ADP ribosylation of the 38-kDa protein was stimulated in a concentration-dependent manner by NO but was not decreased by 1,4-naphthoquinone. In conclusion, NO produces a long-lasting inhibition of vascular contractility by both a cGMP-dependent and -independent mechanism. Based on the observations of 1,4-naphthoquinone, we conclude that the cGMP- independent mechanism is not stimulation of endogenous ADP ribosylation but some other covalent modification in the pathway that mediates contraction.

AB - Nitric oxide (NO) has been postulated as a regulator of vascular reactivity, and the current study tested the hypothesis that NO-induced decreased sensitivity to vasoconstrictors persists following removal of NO. Endothelium-denuded segments of rat aorta were incubated 2-4 h at 37°C with the NO donor S-nitroso-N-acetylpenicillamine (SNAP). Incubation produced rightward shifts in concentration response curves for phenylephrine [i.e., half-maximum effective concentration (EC50; in μM): control = 0.016, NO 0.14], aluminum fluoride (i.e., EC50 in mM: control 1.66, NO = 2.29), and KCI (i.e., EC50 in mM: control = 5.9, NO = 23.9). Similar shifts were seen for two other NO donors. The SNAP-induced shift was not attenuated by a guanylyl cyclase inhibitor, LY-83583 (10 μM) and was not mimicked by 8- bromoguanosine 3',5'-cyclic monophosphate (100 μM). It was attenuated by 1,4-naphthoquinone (50 μM), an inhibitor of endogenous mono-ADP ribosyltransferases. NO incubation increased cGMP content (4.6 ± 0.8 vs. 1.5 ± 0.15 pmol/mg protein), an increase unaffected by 1,4-naphthoquinone (3.3 ± 1.0 pmol/mg protein) but prevented by LY-83583 (1.6 ± 0.36 pmol/mg protein). ADP ribosylation of three proteins was observed in membranes from HEK 293 cells: 88, 66, and 38 kDa. ADP ribosylation of the 38-kDa protein was stimulated in a concentration-dependent manner by NO but was not decreased by 1,4-naphthoquinone. In conclusion, NO produces a long-lasting inhibition of vascular contractility by both a cGMP-dependent and -independent mechanism. Based on the observations of 1,4-naphthoquinone, we conclude that the cGMP- independent mechanism is not stimulation of endogenous ADP ribosylation but some other covalent modification in the pathway that mediates contraction.

KW - adenosine 5'-monophosphate ribosylation

KW - guanosine 3',5'-cyclic monophosphate

KW - guanylyl cyclase

KW - vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0029760272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029760272&partnerID=8YFLogxK

M3 - Article

VL - 271

SP - 253

EP - 260

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 Pt 2

ER -